Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

While studies have shown that reductions in out-of-pocket payments for vaccination generally encourages vaccination uptake, research on the impact on health outcomes has rarely been examined. Thus, the present study, using municipal-level survey data on a subsidy programme for influenza vaccination in Japan that covers the entire country, examines how reductions in out-of-pocket payments for vaccination among non-elderly individuals through a subsidy programme affected regional-level influenza activity. We find that payment reductions are negatively correlated with the number of weeks with a high influenza alert in that region, although the correlation varied across years. At the same time, we find no significant correlation between payment reductions and the total duration of influenza outbreaks (i.e. periods with a moderate or high alert). Given that a greater number of weeks with a high alert indicates a severer epidemic, our findings suggest that reductions in out-of-pocket payments for influenza vaccination among the non-elderly had a positive impact on community-wide health outcomes, indicating that reduced out-of-pocket payments contributes to the effective control of severe influenza epidemics. This suggests that payment reductions could benefit not only individuals by providing them with better access to preventive care, as has been shown previously, but also communities as a whole by shortening the duration of epidemics.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1744133116000037DOI Listing

Publication Analysis

Top Keywords

out-of-pocket payments
20
health outcomes
12
influenza vaccination
12
reductions out-of-pocket
12
payment reductions
12
community-wide health
8
payments vaccination
8
subsidy programme
8
vaccination non-elderly
8
number weeks
8

Similar Publications

Background: To address the opioid use disorder (OUD) public health crisis, the ADvancing Pharmacological Treatments for OUD (ADaPT-OUD) external facilitation randomized trial was conducted in 8 intervention and 27 matched control low-performing Veterans Health Administration (VHA) facilities to increase the prescribing of medications for OUD (MOUD). Facilities were considered low-performers if they were in the bottom quartile of the facility ratio of Veterans with OUD who received MOUD. The objective of this analysis was to evaluate the healthcare expenditures of Veterans with OUD who received care in ADaPT-OUD intervention facilities compared to those receiving care in matched control facilities.

View Article and Find Full Text PDF

Dispensing Patterns of Prescription Medicines Among Older Australians From 2013-2023.

J Am Med Dir Assoc

September 2025

Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Western Australia, Australia.

Objectives: To characterize annual trends in prescription medicine dispensing patterns among Australians ≥65 years of age from 2013-2023.

Design: Population-based retrospective descriptive study.

Setting And Participants: A 10% sample of the Australian Pharmaceutical Benefits Scheme (PBS) dataset covering medicines dispensed between 2013 and 2023.

View Article and Find Full Text PDF

Wearable Point-of-Care Biosensor for Biomolecular Assay in Health Monitoring.

ACS Appl Bio Mater

September 2025

Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, P.R. China.

Wearable biosensors represent a significant advancement in preventive health monitoring by enabling early disease detection through real-time bioanalysis. This review examines the evolution of point-of-care testing (POCT), with a focus on materials, fabrication techniques, and real-world applications. These biosensors utilize advanced materials, such as supramolecular hydrogels, and innovative manufacturing methods, providing high sensitivity, specificity, and portability.

View Article and Find Full Text PDF

Importance: The US Inflation and Reduction Act (IRA) prohibits the Centers for Medicare & Medicaid Services (CMS) from using discriminatory methods such as cost-effectiveness analysis (CEA) that assign lower value to treating sicker and disabled persons. Generalized risk-adjusted cost- effectiveness (GRACE) provides a nondiscriminatory alternative, but the potential impact on health care budgets is unknown.

Objective: To compare value-based drug prices based on traditional CEA with those based on IRA-compliant GRACE and assess the implications for health care budgets.

View Article and Find Full Text PDF

Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor most commonly in China. In 2013, NPC incidence and mortality in China were also at high levels worldwide, which poses a great health burden in China. This study analyzes the medical expenditure and influencing factors of inpatients with NPC and aims to provide reference suggestions for reducing medical expenditure for NPC.

View Article and Find Full Text PDF